Clinical trial
Multi-Omics Testing for Immunotherapy Efficacy Evaluation (MOTIVATION)
NCT04923802
Study timeline
Study start (actual)2021-06-24Date precision: day
Registry last updated2024-03-08
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Non-small Cell Lung Cancerunresolved
Neoantigenunresolved
Next-generation Sequencingunresolved
Biomarkerunresolved
Interventions
Sponsors & collaborators
GeneCast Biotechnology Co., Ltd.lead sponsor
Xinqiao Hospital of Chongqingcollaborator
Shanghai Pulmonary Hospital, Shanghai, Chinacollaborator
Shanghai Chest Hospitalcollaborator
Wuhan Universitycollaborator
Renmin Hospital of Wuhan Universitycollaborator
Tongji Hospitalcollaborator
Southwest Hospital, Chinacollaborator
People's Hospital of Chongqingcollaborator
Sichuan Cancer Hospital and Research Institutecollaborator
Guizhou Provincial People's Hospitalcollaborator
Shanxi Province Cancer Hospitalcollaborator
First Hospital of China Medical Universitycollaborator
Fujian Provincial Hospitalcollaborator
Peking University Shenzhen Hospitalcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04923802 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.